<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26384095</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>01</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>01</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-4954</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2016</Year>
</PubDate>
</JournalIssue>
<Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>
<ISOAbbreviation>J. Matern. Fetal. Neonatal. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Periconceptional risk factors of spina bifida among Egyptian population: a case-control study.</ArticleTitle>
<Pagination>
<MedlinePgn>2264-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3109/14767058.2015.1081890</ELocationID>
<Abstract>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the preconceptual &amp; early conceptional risk factors predisposing to the development of spina bifida (SB) among Egyptian population.</AbstractText>
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">The study involved 197 pregnant women undergoing fetal anatomy scan; 97 women proved to have fetal SB and 100 women with normal fetuses as a control group. The control group was recruited randomly in the same period from patients undergoing anatomical scan. Risk factors that might lead to SB were investigated including maternal age, gravidity, parity, residence, history of diabetes mellitus or drug intake, smoking, infections, exposure to X-ray, history of congenital anomalies in other offspring, parental consanguinity, positive family history, and folate supplementations.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SB affected the lumbo-sacral region in the majority of cases (89.7%). It was associated with hydrocephalus in 66 cases (68%), polyhydramnios in 12 cases (12.4%). The SB group showed significantly higher parity (p = 0.005), more frequent history of drug intake (p &lt; 0.001), higher frequency of infection with CMV (p = 0.004), and HSV (p = 0.013) and less proportion of folate supplementation (p &lt; 0.001).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The rate of SB in the tested group was five per 1000. Risk factors were lack of folate supplementation and history of antiepileptic drugs intake.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Maged</LastName>
<ForeName>Ahmed</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elsherbini</LastName>
<ForeName>Moutaz</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramadan</LastName>
<ForeName>Wafaa</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elkomy</LastName>
<ForeName>Rasha</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Helal</LastName>
<ForeName>Omneya</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hatem</LastName>
<ForeName>Dina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fouad</LastName>
<ForeName>Mona</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gaafar</LastName>
<ForeName>Hassan</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>a Department of Obstetrics and Gynecology , Kasr Aini Hospital Cairo University , Cairo , Egypt.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>09</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>
<NlmUniqueID>101136916</NlmUniqueID>
<ISSNLinking>1476-4954</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>12001-76-2</RegistryNumber>
<NameOfSubstance UI="D014803">Vitamin B Complex</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>935E97BOY8</RegistryNumber>
<NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000927">Anticonvulsants</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003586">Cytomegalovirus Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004534">Egypt</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005492">Folic Acid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006849">Hydrocephalus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015999">Multivariate Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010298">Parity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006831">Polyhydramnios</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011247">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011251">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016135">Spinal Dysraphism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014803">Vitamin B Complex</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">3D ultrasound</Keyword>
<Keyword MajorTopicYN="N">Consanguinity</Keyword>
<Keyword MajorTopicYN="N">hydrocephalus</Keyword>
<Keyword MajorTopicYN="N">spina bifida</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>9</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>9</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>1</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26384095</ArticleId>
<ArticleId IdType="doi">10.3109/14767058.2015.1081890</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>